Biotech Giant Windtree Raises $520M to Forge an Unprecedented BNB Empire
Windtree’s $520M play shifts biotech norms—acquisitions over innovation. Can this strategy sustain real growth, or is it just clever financial engineering?
AI-generated illustration
